TRANSCAT INC (TRNS) Fundamental Analysis & Valuation

NASDAQ:TRNS • US8935291075

Current stock price

75.68 USD
-1.61 (-2.08%)
At close:
75.68 USD
0 (0%)
After Hours:

This TRNS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. TRNS Profitability Analysis

1.1 Basic Checks

  • TRNS had positive earnings in the past year.
  • In the past year TRNS had a positive cash flow from operations.
  • In the past 5 years TRNS has always been profitable.
  • TRNS had a positive operating cash flow in each of the past 5 years.
TRNS Yearly Net Income VS EBIT VS OCF VS FCFTRNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

1.2 Ratios

  • TRNS has a Return On Assets of 1.67%. This is comparable to the rest of the industry: TRNS outperforms 43.48% of its industry peers.
  • Looking at the Return On Equity, with a value of 2.66%, TRNS is in line with its industry, outperforming 43.48% of the companies in the same industry.
  • TRNS has a Return On Invested Capital of 3.14%. This is in the lower half of the industry: TRNS underperforms 60.87% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for TRNS is below the industry average of 9.22%.
Industry RankSector Rank
ROA 1.67%
ROE 2.66%
ROIC 3.14%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
TRNS Yearly ROA, ROE, ROICTRNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • TRNS has a Profit Margin (2.47%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of TRNS has grown nicely.
  • Looking at the Operating Margin, with a value of 5.60%, TRNS is in line with its industry, outperforming 54.35% of the companies in the same industry.
  • TRNS's Operating Margin has improved in the last couple of years.
  • TRNS has a Gross Margin (32.45%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of TRNS has grown nicely.
Industry RankSector Rank
OM 5.6%
PM (TTM) 2.47%
GM 32.45%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
TRNS Yearly Profit, Operating, Gross MarginsTRNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. TRNS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TRNS is destroying value.
  • The number of shares outstanding for TRNS has been increased compared to 1 year ago.
  • The number of shares outstanding for TRNS has been increased compared to 5 years ago.
  • Compared to 1 year ago, TRNS has a worse debt to assets ratio.
TRNS Yearly Shares OutstandingTRNS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
TRNS Yearly Total Debt VS Total AssetsTRNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 3.65 indicates that TRNS is not in any danger for bankruptcy at the moment.
  • TRNS has a Altman-Z score of 3.65. This is in the better half of the industry: TRNS outperforms 60.87% of its industry peers.
  • TRNS has a debt to FCF ratio of 4.02. This is a neutral value as TRNS would need 4.02 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 4.02, TRNS is in the better half of the industry, outperforming 69.57% of the companies in the same industry.
  • TRNS has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.34, TRNS is in the better half of the industry, outperforming 60.87% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 4.02
Altman-Z 3.65
ROIC/WACC0.34
WACC9.16%
TRNS Yearly LT Debt VS Equity VS FCFTRNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.3 Liquidity

  • A Current Ratio of 2.21 indicates that TRNS has no problem at all paying its short term obligations.
  • The Current ratio of TRNS (2.21) is comparable to the rest of the industry.
  • A Quick Ratio of 1.85 indicates that TRNS should not have too much problems paying its short term obligations.
  • TRNS's Quick ratio of 1.85 is fine compared to the rest of the industry. TRNS outperforms 78.26% of its industry peers.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.85
TRNS Yearly Current Assets VS Current LiabilitesTRNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. TRNS Growth Analysis

3.1 Past

  • The earnings per share for TRNS have decreased by -9.19% in the last year.
  • TRNS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.36% yearly.
  • Looking at the last year, TRNS shows a quite strong growth in Revenue. The Revenue has grown by 17.45% in the last year.
  • TRNS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.97% yearly.
EPS 1Y (TTM)-9.19%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%4%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%25.62%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.15% on average over the next years. This is quite good.
  • TRNS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.45% yearly.
EPS Next Y25.77%
EPS Next 2Y21.67%
EPS Next 3Y17.45%
EPS Next 5Y17.15%
Revenue Next Year19.68%
Revenue Next 2Y13.45%
Revenue Next 3Y9.11%
Revenue Next 5Y8.45%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
TRNS Yearly Revenue VS EstimatesTRNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
TRNS Yearly EPS VS EstimatesTRNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

2

4. TRNS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 45.05, TRNS can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, TRNS is valued a bit more expensive than 63.04% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of TRNS to the average of the S&P500 Index (26.91), we can say TRNS is valued expensively.
  • Based on the Price/Forward Earnings ratio of 34.78, the valuation of TRNS can be described as expensive.
  • TRNS's Price/Forward Earnings is on the same level as the industry average.
  • TRNS is valuated expensively when we compare the Price/Forward Earnings ratio to 21.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 45.05
Fwd PE 34.78
TRNS Price Earnings VS Forward Price EarningsTRNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 60.87% of the companies in the same industry are cheaper than TRNS, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of TRNS indicates a somewhat cheap valuation: TRNS is cheaper than 73.91% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 28.39
EV/EBITDA 19.12
TRNS Per share dataTRNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • TRNS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • TRNS's earnings are expected to grow with 17.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.75
PEG (5Y)7.08
EPS Next 2Y21.67%
EPS Next 3Y17.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TRNS Dividend Analysis

5.1 Amount

  • TRNS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TRNS Fundamentals: All Metrics, Ratios and Statistics

TRANSCAT INC

NASDAQ:TRNS (4/28/2026, 8:03:00 PM)

After market: 75.68 0 (0%)

75.68

-1.61 (-2.08%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Industry Strength70.81
Industry Growth45.96
Earnings (Last)02-03
Earnings (Next)05-18
Inst Owners101.52%
Inst Owner Change-6.24%
Ins Owners1.03%
Ins Owner Change0.71%
Market Cap706.09M
Revenue(TTM)319.69M
Net Income(TTM)7.89M
Analysts80
Price Target103.36 (36.58%)
Short Float %6.48%
Short Ratio4.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-19.05%
Min EPS beat(2)-23.53%
Max EPS beat(2)-14.58%
EPS beat(4)2
Avg EPS beat(4)2.74%
Min EPS beat(4)-23.53%
Max EPS beat(4)46.44%
EPS beat(8)4
Avg EPS beat(8)4.49%
EPS beat(12)7
Avg EPS beat(12)2.23%
EPS beat(16)8
Avg EPS beat(16)1.87%
Revenue beat(2)2
Avg Revenue beat(2)0.8%
Min Revenue beat(2)0.17%
Max Revenue beat(2)1.44%
Revenue beat(4)3
Avg Revenue beat(4)1.06%
Min Revenue beat(4)-1.01%
Max Revenue beat(4)3.66%
Revenue beat(8)4
Avg Revenue beat(8)-1.56%
Revenue beat(12)6
Avg Revenue beat(12)-1.1%
Revenue beat(16)8
Avg Revenue beat(16)-0.67%
PT rev (1m)0%
PT rev (3m)-2.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.61%
EPS NY rev (1m)-2.29%
EPS NY rev (3m)-10.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.31%
Valuation
Industry RankSector Rank
PE 45.05
Fwd PE 34.78
P/S 2.21
P/FCF 28.39
P/OCF 17.98
P/B 2.38
P/tB N/A
EV/EBITDA 19.12
EPS(TTM)1.68
EY2.22%
EPS(NY)2.18
Fwd EY2.88%
FCF(TTM)2.67
FCFY3.52%
OCF(TTM)4.21
OCFY5.56%
SpS34.26
BVpS31.81
TBVpS-0.29
PEG (NY)1.75
PEG (5Y)7.08
Graham Number34.6749 (-54.18%)
Profitability
Industry RankSector Rank
ROA 1.67%
ROE 2.66%
ROCE 4.1%
ROIC 3.14%
ROICexc 3.17%
ROICexgc 10.29%
OM 5.6%
PM (TTM) 2.47%
GM 32.45%
FCFM 7.78%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
ROICexc(3y)6.37%
ROICexc(5y)6.98%
ROICexgc(3y)14.95%
ROICexgc(5y)15.39%
ROCE(3y)7.84%
ROCE(5y)8.8%
ROICexgc growth 3Y-9.42%
ROICexgc growth 5Y-3.25%
ROICexc growth 3Y-18.51%
ROICexc growth 5Y-11.8%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
F-Score4
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 4.02
Debt/EBITDA 2.34
Cap/Depr 57.97%
Cap/Sales 4.51%
Interest Coverage 250
Cash Conversion 91.87%
Profit Quality 315.12%
Current Ratio 2.21
Quick Ratio 1.85
Altman-Z 3.65
F-Score4
WACC9.16%
ROIC/WACC0.34
Cap/Depr(3y)85.02%
Cap/Depr(5y)89.69%
Cap/Sales(3y)4.65%
Cap/Sales(5y)4.54%
Profit Quality(3y)129.96%
Profit Quality(5y)134.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-9.19%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%4%
EPS Next Y25.77%
EPS Next 2Y21.67%
EPS Next 3Y17.45%
EPS Next 5Y17.15%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%25.62%
Revenue Next Year19.68%
Revenue Next 2Y13.45%
Revenue Next 3Y9.11%
Revenue Next 5Y8.45%
EBIT growth 1Y-18.8%
EBIT growth 3Y8.38%
EBIT growth 5Y11.83%
EBIT Next Year192.65%
EBIT Next 3Y47.62%
EBIT Next 5Y32.49%
FCF growth 1Y34.44%
FCF growth 3Y51.16%
FCF growth 5Y38.93%
OCF growth 1Y31.51%
OCF growth 3Y30.31%
OCF growth 5Y27.52%

TRANSCAT INC / TRNS Fundamental Analysis FAQ

What is the fundamental rating for TRNS stock?

ChartMill assigns a fundamental rating of 4 / 10 to TRNS.


Can you provide the valuation status for TRANSCAT INC?

ChartMill assigns a valuation rating of 2 / 10 to TRANSCAT INC (TRNS). This can be considered as Overvalued.


Can you provide the profitability details for TRANSCAT INC?

TRANSCAT INC (TRNS) has a profitability rating of 5 / 10.


What is the valuation of TRANSCAT INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for TRANSCAT INC (TRNS) is 45.05 and the Price/Book (PB) ratio is 2.38.